Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
US Department of Justice

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,250,688

« Back to Dashboard

Title: Purine derivatives
Abstract:A compound of formula (I) ##STR1## or a salt thereof, wherein R.sub.1 and R.sub.2 are each independently hydrogen, acyl or phosphate, provided that when one of R.sub.1 or R.sub.2 is phosphate, the other is hydrogen; or R.sub.1 and R.sub.2 are joined together to form a cyclic acetal group, a cyclic carbonate group or a cyclic phosphate group. Processes for preparing these compounds and their use in therapy is also described.
Inventor(s): Harnden; Michael R. (Horsham, GB2), Jarvest; Richard L. (Surbiton, GB2)
Assignee: Beecham Group p.l.c. (GB2)
Filing Date:Jan 22, 1992
Application Number:07/825,440
Claims:1. A compound, having the name 2-amino-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine, of Formula I ##STR18## or a pharmaceutically acceptable salt thereof.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.